Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

17 terminated/withdrawn out of 840 trials

Success Rate

87.9%

+1.4% vs industry average

Late-Stage Pipeline

12%

100 trials in Phase 3/4

Results Transparency

8%

10 of 124 completed trials have results

Key Signals

222 recruiting10 with results10 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
232(40.6%)
Phase 2
151(26.4%)
Phase 1
70(12.3%)
Phase 4
52(9.1%)
Phase 3
48(8.4%)
Early Phase 1
18(3.2%)
571Total
N/A(232)
Phase 2(151)
Phase 1(70)
Phase 4(52)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (840)

Showing 20 of 840 trials
NCT06458244Recruiting

The Efficacy of Allo-HSCT in ND HR-CBF-AML

Role: lead

NCT07531446Active Not Recruiting

Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters

Role: lead

NCT07527689Not ApplicableNot Yet Recruiting

Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer

Role: lead

NCT07202559Not ApplicableRecruiting

Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy

Role: collaborator

NCT07370610Active Not Recruiting

Electrical Impedance Tomography-Based Dynamic Ventilation-Perfusion Functional Phenotype Trajectory in Acute Respiratory Distress Syndrome

Role: lead

NCT07525024Not Yet Recruiting

KSD-101 in Patients With EBV-associated Hematological Malignancies

Role: lead

NCT07191444Recruiting

A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Role: lead

NCT06876792Completed

Electrical Impedance Tomography-derived Flow Index During Spontaneous Breathing Trial Stratifies the Risk of Reintubation Within 48 h After Extubation: A Multicenter Prospective Observational Study

Role: lead

NCT06553053Not ApplicableRecruiting

Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial

Role: collaborator

NCT07368829Not ApplicableRecruiting

AI-Driven Autonomous Registration in Robotic Bronchoscopy

Role: lead

NCT07521111Recruiting

Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients

Role: lead

NCT07504471Phase 2Recruiting

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Role: lead

NCT07489950Not ApplicableCompleted

Non-apnea Saline-contrast EIT for Lung Perfusion Imaging in Spontaneously Breathing Patients

Role: lead

NCT07496385Not ApplicableNot Yet Recruiting

Clinical Study on the Efficacy of Subglottic Suction in Mechanically Ventilated Patients Guided by Bedside Ultrasound

Role: lead

NCT07331883Phase 2Recruiting

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

Role: lead

NCT07498855Recruiting

Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation

Role: lead

NCT07496411Not ApplicableNot Yet Recruiting

Predictive Validity and Clinical Utility of an Ultrasound-based Quantitative Risk Score for Pressure Injury in Critically Ill Patients: A Two-Phase Sequential Study

Role: lead

NCT07493330Phase 1Not Yet Recruiting

Genotype-guided Targeted Agents Plus EZH2i for Primary Refractory PTCL

Role: lead

NCT06793189Phase 2Recruiting

MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL

Role: lead

NCT06538623Phase 2Completed

Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer

Role: lead